As drug shortages stabilize and demand for weight management therapies remains strong, regulators are placing greater emphasis on product quality, lawful compounding practices, accurate marketing, and patient protection
The dosing transition between these medications requires careful planning to maintain receptor engagement without overtreating or undertreating
In contrast, the participants in the trial not taking tirzepatide showed the expected, elevated NAc activity and frequent episodes of food preoccupation, consistent with earlier findings from the Halpern Lab
3,4 Another agent gaining in popularity is tirzepatide (Mounjaro, Zepbound), a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 RA
Mental health problems and social media exposure during COVID-19 outbreak
Lam CSP, Brutsaert DL